Clinical Trials Browser

Terminated × Neoplasms × dabrafenib × Clear all

NCT04801966 2023-05-10

TAILOR

Phase NA Terminated

Neoplasms

NCT02314143 2019-02-18

Phase II Biomarker Study Comparing the Combination of BRAF Inhibitor Dabrafenib With MEK Inhibitor Trametinib Versus the Combination After Monotherapy With Dabrafenib or Trametinib

Phase 2 Terminated

48 enrolled 20 charts

Melanoma, Neoplasms